Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Bonner

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Frontiers in Pharmacology|July 8, 2014
Fibrocytes in the fibrotic lung: altered phenotype detected by flow cytometryCharles Reese, Rebecca Lee, Michael Bonner, et al.
Journal of General Internal Medicine|December 13, 2005
The roles of low literacy and social support in predicting the preventability of hospital admissionAhsan M Arozullah, Shoou-Yih D Lee, Taha Khan, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 4, 2014
Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung diseaseRebecca Lee, Charles Reese, Michael Bonner, et al.
Inflammatory Bowel Diseases|September 18, 2010
QuantiFERON TB gold testing for tuberculosis screening in an inflammatory bowel disease cohort in the United StatesBashar J Qumseya, Ashwin N Ananthakrishnan, Sue Skaros, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
Adipose-derived mesenchymal stromal/stem cells in systemic sclerosis: Alterations in function and beneficial effect on lung fibrosis are regulated by caveolin-1Rebecca Lee, Nicoletta Del Papa, Martin Introna, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 22, 2008
Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivoElena Tourkina, Mathieu Richard, Pal Gööz, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 1, 2014
Caveolin-1 deficiency may predispose African Americans to systemic sclerosis-related interstitial lung diseaseCharles Reese, Beth Perry, Jonathan Heywood, et al.
Frontiers in Pharmacology|June 27, 2014
Caveolin-1 regulates chemokine receptor 5-mediated contribution of bone marrow-derived cells to dermal fibrosisRebecca Lee, Beth Perry, Jonathan Heywood, et al.
Methods and Protocols|January 23, 2025
Evaluation of Drug-Polymer and Drug-Drug Interaction in Cellulosic Multi-Drug Delivery MatricesAbdullah Isreb, Mohamed A Alhnan, Abdulrahman Mkia, et al.
Fibrogenesis & Tissue Repair|July 5, 2011
Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptideElena Tourkina, Michael Bonner, James Oates, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Frontiers in Pharmacology|July 8, 2014
Fibrocytes in the fibrotic lung: altered phenotype detected by flow cytometryCharles Reese, Rebecca Lee, Michael Bonner, et al.
Journal of General Internal Medicine|December 13, 2005
The roles of low literacy and social support in predicting the preventability of hospital admissionAhsan M Arozullah, Shoou-Yih D Lee, Taha Khan, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 4, 2014
Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung diseaseRebecca Lee, Charles Reese, Michael Bonner, et al.
Inflammatory Bowel Diseases|September 18, 2010
QuantiFERON TB gold testing for tuberculosis screening in an inflammatory bowel disease cohort in the United StatesBashar J Qumseya, Ashwin N Ananthakrishnan, Sue Skaros, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
Adipose-derived mesenchymal stromal/stem cells in systemic sclerosis: Alterations in function and beneficial effect on lung fibrosis are regulated by caveolin-1Rebecca Lee, Nicoletta Del Papa, Martin Introna, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 22, 2008
Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivoElena Tourkina, Mathieu Richard, Pal Gööz, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 1, 2014
Caveolin-1 deficiency may predispose African Americans to systemic sclerosis-related interstitial lung diseaseCharles Reese, Beth Perry, Jonathan Heywood, et al.
Frontiers in Pharmacology|June 27, 2014
Caveolin-1 regulates chemokine receptor 5-mediated contribution of bone marrow-derived cells to dermal fibrosisRebecca Lee, Beth Perry, Jonathan Heywood, et al.
Methods and Protocols|January 23, 2025
Evaluation of Drug-Polymer and Drug-Drug Interaction in Cellulosic Multi-Drug Delivery MatricesAbdullah Isreb, Mohamed A Alhnan, Abdulrahman Mkia, et al.
Fibrogenesis & Tissue Repair|July 5, 2011
Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptideElena Tourkina, Michael Bonner, James Oates, et al.
Pageof 3